A detailed history of Oak Harbor Wealth Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oak Harbor Wealth Partners, LLC holds 6,535 shares of BMY stock, worth $376,285. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,535
Previous 6,223 5.01%
Holding current value
$376,285
Previous $258,000 31.01%
% of portfolio
0.1%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$39.66 - $51.75 $12,373 - $16,146
312 Added 5.01%
6,535 $338,000
Q2 2024

Jul 18, 2024

BUY
$40.25 - $52.99 $16,784 - $22,096
417 Added 7.18%
6,223 $258,000
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $8,828 - $10,009
-184 Reduced 3.07%
5,806 $314,000
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $5,235 - $6,247
108 Added 1.84%
5,990 $307,000
Q3 2023

Oct 19, 2023

BUY
$57.89 - $64.73 $752 - $841
13 Added 0.22%
5,882 $341,000
Q2 2023

Jul 27, 2023

SELL
$63.71 - $70.74 $28,733 - $31,903
-451 Reduced 7.14%
5,869 $375,000
Q1 2023

Apr 24, 2023

SELL
$65.71 - $74.53 $21,684 - $24,594
-330 Reduced 4.96%
6,320 $438,000
Q4 2022

Jan 18, 2023

BUY
$68.48 - $81.09 $616 - $729
9 Added 0.14%
6,650 $0
Q3 2022

Nov 03, 2022

BUY
$0.13 - $76.84 $1 - $691
9 Added 0.14%
6,641 $472,000
Q2 2022

Jul 25, 2022

BUY
$72.62 - $79.98 $653 - $719
9 Added 0.14%
6,632 $511,000
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $614 - $737
10 Added 0.15%
6,623 $484,000
Q4 2021

Feb 17, 2022

BUY
$53.63 - $62.52 $354,655 - $413,444
6,613 New
6,613 $412,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Oak Harbor Wealth Partners, LLC Portfolio

Follow Oak Harbor Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Harbor Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Harbor Wealth Partners, LLC with notifications on news.